Encephalitis, Japanese B Completed Phase 2 Trials for Japanese encephalitis virus strain sa 14-14-2 antigen (formaldehyde inactivated) (DB10769)

Also known as: Japanese Encephalitis / Encephalitis Japanese B / Encephalitis, Japanese / Japanese B encephalitis / Japanese B viral encephalitis

IndicationStatusPhase
DBCOND0033957 (Encephalitis, Japanese B)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00621764Immunogenicity and Safety of ChimeriVax™ Japanese Encephalitis Vaccine in Thai Toddlers and ChildrenPrevention
NCT01943305The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans